Copyright 2024
| PMID | Allele | Disease | Population | Drug Names | SNP | Class | Sentence |
|---|---|---|---|---|---|---|---|
| 33179442 | HLA (HLA) | hematopoietic stem cell transplantation | Korean | NA | NA | unclassified | |
| hla genes play a pivotal role for successful hematopoietic stem cell transplantation (hsct). | |||||||
| 33240273 | HLA (HLA) | hematopoietic stem cell transplantation | African | NA | NA | unclassified | |
| a match of hla loci between patients and donors is critical for successful hematopoietic stem cell transplantation. | |||||||
| 33329605 | HLA MATCHED (HLA-MATCHED) | hematopoietic stem cell transplantation | NA | NA | NA | unclassified | |
| the treatment of choice for these patients is hematopoietic stem cell transplantation, with an excellent survival rate (>90%) if an hla-matched sibling donor is available. | |||||||
| 33388454 | HLA (HLA) | hematopoietic stem cell transplantation | NA | NA | NA | unclassified | |
| so, analyzing the outcomes of allogeneic hematopoietic stem cell transplantation is a good opportunity to know the antitumor effects and regulatory effects of nk cells through hla class 1 matching and mismatching of donor and recipient. | |||||||
| 33431182 | HLA IDENTICAL (HLA-IDENTICAL) | hematopoietic stem cell transplantation | NA | NA | NA | unclassified | |
| nowadays, allogeneic hematopoietic stem cell transplantation is the only curative treatment, recommended only in selected cases of severely affected patients with an hla-identical donor. | |||||||
| 33551435 | HLA (HLA) | hematopoietic stem cell transplantation | NA | cyclophosphamide | NA | unclassified | |
| immune reconstitution after t-cell replete hla haploidentical hematopoietic stem cell transplantation using high-dose post-transplant cyclophosphamide. | |||||||
| 33551435 | HLA (HLA) | hematopoietic stem cell transplantation | NA | cyclophosphamide | NA | unclassified | |
| as hla haploidentical related donors are quickly available, hla haploidentical hematopoietic stem cell transplantation (haplohsct) using high-dose post-transplant cyclophosphamide (ptcy) is now widely used. | |||||||
| 33590333 | HLA (HLA) | hematopoietic stem cell transplantation | NA | NA | NA | unclassified | |
| purposethe most important hla-independent factor for the selection of cord blood units (cbu) for hematopoietic stem cell transplantation is the total nucleated cell (tnc) count over 150 x 107 as a surrogate marker for stem cell content. | |||||||
| 33610676 | HLA (HLA) | hematopoietic stem cell transplantation | NA | NA | NA | unclassified | |
| analysis of hla haplotype and clinical factors during hematopoietic stem cell transplantation. | |||||||
| 33610676 | HUMAN LEUKOCYTE ANTIGEN (HUMAN LEUKOCYTE ANTIGEN) | hematopoietic stem cell transplantation | NA | NA | NA | unclassified | |
| the human leukocyte antigen (hla) haplotype of the recipient in hematopoietic stem cell transplantation (hsct) is a key factor in its success or failure. | |||||||
Copyright 2024